Clinical Trial Update: BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating BOLD-100 in combination with FOLFOX for advanced solid tumors, including colorectal cancer, pancreatic cancer, gastric can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Colorectal Cancer
• Gastric Cancer
• Pancreatic Cancer

Drugs mentioned

• BOLD-100
• FOLFOX

Snippet

Sponsor: Bold Therapeutics, Inc. | Conditions: Colorectal Cancer, Pancreatic Cancer | Phase 1, Phase 2 | Status: RECRUITING